Edward M Behrens Selected Research

Edward M Behrens Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 09/2014
10	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2024 - 10/2006
10	Cytokine Release Syndrome 01/2023 - 09/2014
8	Macrophage Activation Syndrome 01/2023 - 02/2011
5	COVID-19 05/2021 - 08/2020
4	Communicable Diseases (Infectious Diseases) 01/2022 - 11/2020
4	Infections 05/2021 - 01/2014
4	Neoplasms (Cancer) 11/2020 - 07/2004
3	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2016
3	Anemia 01/2022 - 07/2013
3	Thrombotic Microangiopathies 12/2021 - 12/2020
3	COVID-19 related pediatric multisystem inflammatory disease 05/2021 - 08/2020
3	Lymphopenia (Lymphocytopenia) 01/2021 - 10/2020
3	Hypersensitivity (Allergy) 11/2020 - 09/2015
3	Autoimmune Diseases (Autoimmune Disease) 10/2015 - 08/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2023 - 01/2014
2	Hepatitis 01/2023 - 01/2022
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023 - 01/2014
2	Vascular System Injuries 12/2021 - 04/2021
2	Critical Illness (Critically Ill) 12/2020 - 11/2020
2	Leukemia 11/2020 - 01/2014
2	Weight Loss (Weight Reduction) 01/2020 - 03/2016
2	Rheumatic Diseases (Rheumatism) 04/2013 - 02/2011
1	Biliary Atresia 01/2024
1	Pneumonia (Pneumonitis) 01/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	cell-associated neurotoxicity 01/2022
1	Eczema 01/2022
1	Hepatomegaly 01/2022
1	Leukopenia 01/2022
1	Neutropenia 01/2022
1	Thrombocytosis (Thrombocythemia) 01/2022
1	Wiskott-Aldrich Syndrome 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Sensorineural Hearing Loss 11/2021
1	Obesity 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Multiple Sclerosis 01/2021
1	Shock 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Lymphoma (Lymphomas) 11/2020
1	Asthma (Bronchial Asthma) 11/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2020
1	Hyponatremia 11/2020
1	Ascorbic Acid Deficiency (Vitamin C Deficiency) 06/2020
1	Scurvy (Scorbutus) 06/2020
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2020
1	Cytopenia 01/2020
1	Anaphylaxis (Anaphylactic Shock) 12/2019

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 01/2022 - 08/2003
6	InterferonsIBA 01/2022 - 07/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2015
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 01/2012
3	ProteomeIBA 01/2022 - 04/2021
3	Interleukin-33IBA 11/2020 - 01/2018
3	InterleukinsIBA 12/2019 - 09/2015
2	EmapalumabIBA 03/2024 - 01/2023
2	Immunoglobulin G (IgG)IBA 05/2021 - 08/2020
2	AntibodiesIBA 01/2021 - 10/2020
2	Interleukin-10 (Interleukin 10)IBA 11/2020 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2015
2	Toll-Like Receptor 9IBA 01/2019 - 01/2017
1	biliatresoneIBA 01/2024
1	Prednisone (Sone)FDA LinkGeneric 11/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	baricitinibIBA 01/2022
1	tisagenlecleucelIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Wiskott-Aldrich Syndrome ProteinIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 11/2021
1	Qa-SNARE Proteins (Syntaxin)IBA 11/2021
1	AntigensIBA 08/2021
1	Thymic Stromal LymphopoietinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2021
1	monomethyl fumarateIBA 01/2021
1	Dimethyl FumarateIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Immunomodulating AgentsIBA 12/2020
1	Complement System Proteins (Complement)IBA 12/2020
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 11/2020
1	CreatinineIBA 11/2020
1	CollagenIBA 06/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Nonsense Codon (Nonsense Mutation)IBA 01/2020
1	tocilizumab (atlizumab)FDA Link 12/2019

Therapy/Procedure

5	Therapeutics 01/2023 - 10/2015
5	Critical Care (Surgical Intensive Care) 01/2022 - 11/2020
2	Immunomodulation 01/2023 - 12/2020
1	Aftercare (After-Treatment) 01/2023